Barclays raised the firm’s price target on Carter’s (CRI) to $26 from $23 and keeps an Underweight rating on the shares ahead of the Q3 report. The firm remains cautious on the shares for 2026, citing uncertainty on the company’s expectations for both sales and earnings growth. Carter’s is facing pressures from consumer responses to higher pricing in the first half of the year, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRI:
- Carter’s Inc. Faces Risks and Challenges in Restructuring Efforts: Potential Impacts on Profitability
- Carter’s Inc. Reports Q3 2025 Earnings and Strategic Actions
- Carter’s Inc. Earnings Call: Growth Amid Challenges
- Carter’s price target raised to $26 from $25 at BofA
- Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations